Clinical trial
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid…
NCT00390000 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00390000 |
|---|---|
| Title | Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA) |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other, Procedure |
| Interventions | vatalanib, pemetrexed disodium, pharmacological study, ultrasound imaging |
| Enrollment | 29 |
| Start date | Jan 25, 2007 |
| Primary completion | Aug 4, 2016 |
| Completion | Aug 4, 2016 |
| First posted | Oct 19, 2006 |
| Last update posted | Apr 8, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: